Royalty Pharma plc stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Royalty Pharma plc stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Royalty Pharma plc do? Business model and key facts
Get the full picture of Royalty Pharma plc: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Biotechnology
Employees (FY): 75
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Stocks related to Royalty Pharma plc
Selected based on industry alignment and relative market positioning.
Events and news impacting Royalty Pharma plc stock
Earnings, coporate decisions and industry developments that can affect the share price.
Royalty Pharma plc fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
